These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 32187230

  • 21. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
    You Y, Qin Y, Lin X, Yang F, Li J, Sooranna SR, Pinhu L.
    BMC Nephrol; 2015 Aug 27; 16():148. PubMed ID: 26310926
    [Abstract] [Full Text] [Related]

  • 22. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S.
    Nephron; 1993 Aug 27; 64(3):471-5. PubMed ID: 7688103
    [Abstract] [Full Text] [Related]

  • 23. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 24. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 25. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE.
    J Immunol; 1988 Jul 01; 141(1):118-24. PubMed ID: 3259964
    [Abstract] [Full Text] [Related]

  • 26. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
    Richard EM, Thiyagarajan T, Bunni MA, Basher F, Roddy PO, Siskind LJ, Nietert PJ, Nowling TK.
    PLoS One; 2013 Jul 01; 8(9):e75175. PubMed ID: 24040398
    [Abstract] [Full Text] [Related]

  • 27. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.
    Fan X, Wüthrich RP.
    Inflammation; 1997 Feb 01; 21(1):105-12. PubMed ID: 9179626
    [Abstract] [Full Text] [Related]

  • 28. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar 01; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 29. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
    Ding ZX, Yang SF, Wu QF, Lu Y, Chen YY, Nie XL, Jie HY, Qi JM, Wang FS.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr 01; 31(4):656-60. PubMed ID: 21515463
    [Abstract] [Full Text] [Related]

  • 30. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z, Liu D, Zhang X, Wang X.
    Inflammation; 2018 Oct 01; 41(5):1888-1899. PubMed ID: 29951872
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
    Liao R, Liu Q, Zheng Z, Fan J, Peng W, Kong Q, He H, Yang S, Chen W, Tang X, Yu X.
    PLoS One; 2015 Oct 01; 10(7):e0132724. PubMed ID: 26161538
    [Abstract] [Full Text] [Related]

  • 32. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis.
    Benz PS, Fan X, Wüthrich RP.
    Kidney Int; 1996 Jul 01; 50(1):156-63. PubMed ID: 8807584
    [Abstract] [Full Text] [Related]

  • 33. Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis.
    Qin L, Du Y, Ding H, Haque A, Hicks J, Pedroza C, Mohan C.
    Arthritis Res Ther; 2019 Jan 08; 21(1):12. PubMed ID: 30621761
    [Abstract] [Full Text] [Related]

  • 34. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.
    Arthritis Rheum; 2002 Nov 08; 46(11):3083-95. PubMed ID: 12428253
    [Abstract] [Full Text] [Related]

  • 35. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
    Wu X, Guo J, Ding R, Lv B, Bi L.
    Acta Histochem; 2015 Oct 08; 117(8):732-7. PubMed ID: 26456520
    [Abstract] [Full Text] [Related]

  • 36. P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI.
    Zhang L, Chen S, Liu Y, Xu X, Zhang Q, Shao S, Wang W, Li X.
    J Transl Med; 2020 Mar 05; 18(1):116. PubMed ID: 32138730
    [Abstract] [Full Text] [Related]

  • 37. Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites.
    Spurney RF, Ruiz P, Pisetsky DS, Coffman TM.
    Kidney Int; 1991 Jan 05; 39(1):95-102. PubMed ID: 1848329
    [Abstract] [Full Text] [Related]

  • 38. Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1.
    Tseng TC, Huang DY, Lai LC, Hwai H, Hsiao YW, Jhou JP, Chuang EY, Tzeng SJ.
    J Mol Med (Berl); 2018 May 05; 96(5):413-425. PubMed ID: 29508016
    [Abstract] [Full Text] [Related]

  • 39. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
    Yang H, Xu A, Lv J, Liu Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun 05; 32(6):821-5. PubMed ID: 22699062
    [Abstract] [Full Text] [Related]

  • 40. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 05; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.